Biomarkers Kidney Disease Quality of Life 
DAIC
MARCH 25, 2025
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25
DAIC
MARCH 25, 2025
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25
Cardiometabolic Health Congress
AUGUST 8, 2024
Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life. This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. Here are four key strategies to achieve this: 1.Shared
GEMMS
MAY 22, 2024
Much of heart disease is linked to conditions like diabetes, obesity, or chronic kidney disease, and specific mutations in nucleic acids help identify them. Genetic testing and DNA sequencing improve the accuracy of predicting heart disease risk.
Cardiometabolic Health Congress
NOVEMBER 14, 2024
What better way to join the fall festivities than by spotlighting key insights in cardiorenal metabolic medicine, primary prevention, and quality of life improvements shared at this year’s biggest U.S. cardiometabolic health CME/CE conference: the 19th Annual CMHC. In the U.S.,
Expert insights. Personalized for you.
52 
Let's personalize your content